The key guidelines for neonatal disorders focus on various aspects, including drug development, clinical trials, and post-market surveillance. For instance, the FDA provides specific guidelines on conducting [pediatric clinical trials](), which include considerations for neonates. Similarly, the EMA has guidelines on the [development of medicinal products]() for pediatric populations.
